Elicera Therapeutics AB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Elicera Therapeutics AB

Watchlist Manager

Watchlist

Price: 0.2335 EUR -2.91% Market Closed

Market Cap: €8.2m

	Elicera Therapeutics AB F:8E8	SE
T	Trencor Ltd JSE:TRE	ZA
A	Alpha Pro Tech Ltd F:APL	CA
A	Arinsiri Land PCL SET:ARIN	TH
B	BuilderSmart PCL SET:BSM	TH
	Giocamondo Study SpA MIL:GMS	IT
J	Johan Holdings Bhd KLSE:JOHAN	MY
S	Shinwon Construction Co Ltd KOSDAQ:017000	KR
J	Jost AG SWB:JOX	DE

Profitability Summary

Elicera Therapeutics AB's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-141%

Negative 3Y Average Operating Margin

-231%

Declining Operating Margin

-135% > -141%

Negative Net Margin

-136%

Negative 3Y Average Net Margin

-221%

Declining Net Margin

-133% > -136%

Negative Free Cash Flow Margin

-261%

Negative 3Y Average Free Cash Flow Margin

-237%

Declining Free Cash Flow Margin

-110% > -261%

Negative ROE

-57%

Negative 3Y Average ROE

Exceptional 3Y Average ROIC

2,452%

ROIC is Increasing

3,138% > 3,274%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.